<DOC>
	<DOC>NCT01114490</DOC>
	<brief_summary>This study will evaluate the Area Under the Curve (AUC(0 to infinity)) of anacetrapib.</brief_summary>
	<brief_title>Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039)</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<mesh_term>Anacetrapib</mesh_term>
	<mesh_term>Oxazolidinones</mesh_term>
	<criteria>Female subjects of reproductive potential test negative for pregnancy and agree to use two acceptable methods of birth control throughout the study Subject is in good health Subject agrees to refrain from consumption of red wine, grapefruit, orange and apple juices throughout the study Patient has a history of cancer Patient is a nursing mother Patient is unable to refrain from or anticipates the use of any prescription or nonprescription medication during the study Patient consumes excessive amounts of alcohol or caffeine Patient has had major surgery, donated blood or participated in another investigational study within the past 4 weeks</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Hepatic Insufficiency</keyword>
</DOC>